References
- Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J. Exp. Med.137(5), 1142–1162 (1973).
- Banchereau J, Schuler-Thurner B, Palucka AK, Schuler G. Dendritic cells as vectors for therapy. Cell106, 271–274 (2001).
- Rutella S, Danese S, Leone G. Tolerogenic dendritic cells: cytokine modulation comes of age. Blood108, 1435–1440 (2006).
- von Bergwelt-Baildon MS, Saric T, Chemnitz J et al. CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition. Blood108, 228–237 (2006).
- Gunzer MJS, Varga G, Grabbe S. Dendritic cells and tumor immunity. Semin. Immunol.13, 291–302 (2001).
- Barratt-Boyes SM, Zimmer MI, Harshyne LA et al. Maturation and trafficking of monocyte-derived dendritic cells in monkeys: implications for dendritic cell-based vaccines. J. Immunol.164, 2487–2495 (2000).
- Maus MV, Thomas AK, Leonard DG et al. Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB. Nat. Biotechnol.20, 143–148 (2002).
- Latouche JB, Sadelain M. Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cells. Nat. Biotechnol.18, 405–409 (2000).
- Schultze JL, Michalak S, Seamon MJ et al. CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy. J. Clin. Invest.100, 2757–2765 (1997).
- von Bergwelt-Baildon MS, Popov A, Klein-Gonzalez N et al. CD40-activated B cells express full lymph node homing triad and induce T-cell chemotaxis: potential as cellular adjuvants. Blood107, 2786–2789 (2006).
- Kondo E, Kiem HP, Obata Y et al. Efficient generation of antigen-specific cytotoxic T cells using retrovirally transduced CD40-activated B cells. J. Immunol.169, 2164–2171 (2002).
- Fuchs E. B cells turn off virgin but not memory T cells. Science258, 1156–1159 (1992).
- Mizoguchi A, Bhan AK. A case for regulatory B cells. J. Immunol.175, 705–710 (2006).
- Fillatreau S, McGeachy MJ, Gray D, Anderton SM. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol.3, 944–950 (2002).
- Knoechel B, Kahn E, Abbas AK. The link between lymphocyte deficiency and autoimmunity: roles of endogenous T and B lymphocytes in tolerance. J. Immunol.175, 21–26 (2005).
- Gunzer M, Hillmer A, Basoglu Y et al. A spectrum of biophysical interaction modes between T cells and different antigen-presenting cells during priming in 3-D collagen and in vivo. Blood104, 2801–2809 (2004).
- Gunzer M, Borgmann S, Grabbe S et al. Antigen presentation in extracellular matrix: interactions of T cells with dendritic cells are dynamic, short lived, and sequential. Immunity13, 323–332 (2000).
- Okada T, Parker I, Krummel MF et al. Antigen-engaged B cells undergo chemotaxis toward the T zone and form motile conjugates with helper T cells. PLoS Biol.3, e150 (2005).
- Reichhardt P, Dornbach B, Rong S et al. Naive B cells generate regulatory T cells in the presence of a mature immunologic synapse. Blood110 (5), 1519–1529 (2007).
- Steinman RM, Nussenzweig MC. Tolerogenic dendritic cells. Ann. Rev. Immunol.21, 685–711 (2001).
- Black RA, Kozlosky CJ, Peschon JJ et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells. Nature385, 729–733 (1997).
- Jung TM. Rapid modulation of homing receptors (gp90MEL-14) induced by activators of protein kinase C. Receptor shedding due to accelerated proteolytic cleavage at the cell surface. J. Immunol.144, 3130–3136 (1990).
- Brossard C, Schmitt A, Randriamampita C, Romao M, Raposo G, Trautmann A. Multifocal structure of the T cell – dendritic cell synapse. Eur. J. Immunol.35, 1741–1753 (2005).
- Coughlin CM, Vance BA, Grupp SA, Vonderheide RH. RNA-transfected CD40-activated B cells induce functional T cell responses against viral and tumor antigen targets: implications for pediatric immunotherapy. Blood103(6), 2046–2054 (2003).
- Yamazaki S, Inaba K, Tarbell KV, Steinman RM. Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T-cells including suppressors of alloreactivity. Immunol. Rev.212, 314–329 (2005).
- McCurry KR, Colvin BL, Zahorchak AF, Thomson AW. Regulatory dendritic cell therapy in organ transplantation. Transpl. Int.19, 525–538 (2006).